Effects of PR Oxycodone and of Levodopa, vs Placebo, on Central Neuropathic Pain in Parkinson's Disease
Status:
Recruiting
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
This study will be conducted in three parallel groups receiving oxycodone, levodopa or
placebo, administered as an add-on therapy, in addition to the usual antiparkinsonian
treatment. As this study focuses on chronic central neuropathic pain caused by PD, the
effects of study treatments will be evaluated after a 10-week treatment period